His-OGT WT or OGT D554N proteins were purified from E. Coli as previously described (Janetzko et al., 2016 (link)), and used to process the in vitro translated HCF-1. Briefly, 5 μl of the in vitro synthesized HCF-1 protein was incubated with 35 μl of in vitro cleavage and O-GlcNAcylation assay buffer (20 mM Tris/HCl pH 7.5, 120 mM NaCl, 2 mM MgCl, 2 mM UDP-GlcNAc, 1mM fresh DTT) containing 1 or 2 μg of His-OGT WT or OGT D554N for 3 hrs at 37°C.
For interaction assays, endogenous ChREBP was bound to protein G agarose beads as described in the immunoprecipitation method above. 30 μl of pre-washed, ChREBP bound beads was incubated with 40 μl of the in vitro processed HCF-1 protein that was diluted in 110 μl of Co-IP lysis buffer (20 mM Tris/HCl pH 7.5, 137 mM NaCl, 5% glycerol, 2 mM EDTA, 2 mM Na3VO4, Complete™ EDTA-free Protease Inhibitor Cocktail, Phosphatase inhibitor cocktail 3, 2 μM Thiamet-G, 10 μM PUGNAc, 1 μM TSA, 0.15% Triton-X100). After 1 hr rotation at 4°C, the complex was washed 2 times with lysis buffer, eluted in 50 μl of 2X LDS sample buffer (Life Technologies) and boiled for 15 min for western blot analysis.